Red X iconGreen tick iconYellow tick icon

Contact Details

Phone
+64 3 479 7133
Email
greg.walker@otago.ac.nz
Position
Associate Professor and Associate Dean (Research), School of Pharmacy, and Head of the Bayer Centre for Dairy Animal Health / Pharmaceutical Science and Product Innovations
Qualifications
BSc MSc PhD(Otago)
Research summary
Drug delivery and formulation
Teaching
  • PHCY211: Fundamental Pharmaceutical Sciences (Dosage forms module coordinator)
  • PHCY220: Integrated modules A
  • PHCY430: Elective Projects B
  • PHCY485: Honours
Memberships
  • Controlled Release Society (2012-present)
  • New Zealand Chapter of the Controlled Release Society (2012 to present): President of the Society (November 2017 to present)

Research

Associate Professor Walker’s general area of research interest is in formulation and delivery of bioactive molecules. Particular interests are in physico-chemical principles relating to how delivery systems can influence the absorption, disposition and fate of bioactives in the body and how such systems can increase the efficacy of bioactives.

He has extensive experience in polymeric drug delivery systems, engineering formulations for biopharmaceuticals, project management and pre-clinical studies.

Prior to joining University of Otago as a lecturer, he was the Research and Development Manager at a UK biotech company where he invented the lead technology of a new class of topical haemostat (PeproStat) which has completed successful phase two clinical trials.

As head of the Bayer Centre for Dairy Animal Health / Pharmaceutical Science and Product Innovations at the School of Pharmacy, he applies his formulation and drug delivery expertise to issues relating to veterinary and animal health.

Associate Professor Walker is a key researcher in three Ministry of Business, Innovation and Employment (MBIE) grants totalling to over NZ $19 million. These projects focus on the formulation and delivery of: vaccines, a new class of antimicrobials and bioactives to crops.

PhD projects are available, please contact me if you are interested in conducting PhD research in the field of formulation and drug delivery.

Publications

Krittaphol, W., Martin, L. W., Lamont, I. L., & Walker, G. F. (2025). A sensitive reverse-phase ultra performance liquid chromatography-tandem mass spectrometry method for the determination of tobramycin in Pseudomonas aeruginosa cell lysate. Journal of Pharmaceutical & Biomedical Analysis, 260, 116743. doi: 10.1016/j.jpba.2025.116743 Journal - Research Article

Krittaphol, W., Martin, L. W., Walker, G. F., & Lamont, I. L. (2025). Anaerobiosis and mutations can reduce susceptibility of Pseudomonas aeruginosa to tobramycin without reducing the cellular concentration of the antibiotic. Pathogens, 14, 187. doi: 10.3390/pathogens14020187 Journal - Research Other

Fairhall, J., Yap, P. J., Godwin, T., Krittaphol Bailey, P., Walker, G., Gamble, A., & Guilford, P. (2024). Acid-cleavable polymer-drug conjugates for targeted delivery to the stomach. Proceedings of the New Zealand Institute of Chemistry (NZIC) Conference. (pp. 10). Retrieved from https://nzic.org.nz/conferences Conference Contribution - Published proceedings: Abstract

Shah, R. M., Reily-Bell, M. J., Walker, G., Katare, R., & Das, S. (2024, November). Investigating microRNAs biomarker potential and their encapsulation in cationic liposomes for targeted lung delivery. Verbal presentation at the School of Pharmacy Research Symposium, Dunedin, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs

Walker, G. (2024, November). Bridging the gap: Research collaboration between academia and industry. Verbal presentation at the School of Pharmacy Research Symposium, Dunedin, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs

Back to top